Fortis Malar Hospitals Limited

Fortis Malar Hospitals Ltd has announced the closure of its trading window for dealing in the company's shares. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the quarter ending on June 30, 2026. This measure is in compliance with the company's Insider Trading Prevention Policy.

Fortis Malar Hospitals Ltd has submitted a report on the status of re-lodgement of transfer requests for physical shares for the months of March and April 2026, as per SEBI circulars. In March 2026, 394 requests were received, processed, and rejected, with an average processing time of 6 days. For April 2026, no requests were received, processed, approved, or rejected.

Fortis Malar Hospitals Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. B S R & Co. LLP issued an unmodified audit opinion on the financial statements. The board also adopted modifications to the policy for determining the materiality of events and updated the policy/code of conduct for the prevention of insider trading. The meeting concluded at 03:35 PM (IST).

Fortis Malar Hospitals Ltd announced the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results, along with the auditor's report from M/s B S R & Co. LLP with an unmodified opinion, were approved by the Board of Directors in a meeting held on May 18, 2026. The company also adopted modifications to the policy for determining the materiality of events and updated the policy/code of conduct for the prevention of insider trading. The company has ceased business operations after a slump sale transaction and is evaluating corporate restructuring options.

Fortis Malar Hospitals Ltd has scheduled a Board of Directors meeting on May 18, 2026, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026. The trading window will remain closed until 48 hours after the announcement of the financial results, i.e., up to May 20, 2026.

Fortis Malar Hospitals Ltd has successfully processed its rectification application against a demand of INR 20.82 Lakhs raised by the Income Tax department, Bengaluru for AY 2024-25. The Centralized Processing Centre (CPC) has processed the rectification application filed under section 154 of the Income Tax Act, 1961 against the Intimation Order under section 143(1) of the Income Tax Act, 1961 for AY 2024-25. The demand has been deleted and a refund of Rs.41.11 lakhs has been determined.

Fortis Malar Hospitals Ltd has announced the closure of its trading window for dealing in shares of the company. The closure will be in effect from April 1, 2026 till 48 hours after the declaration of Audited Financial Results for the quarter and financial year ended on March 31, 2026. This disclosure is in accordance with the Policy / Code of Conduct for Prevention of Insider Trading.

Fortis Malar Hospitals Ltd. has received an Income Tax rectification order dated March 19, 2026 for the assessment year 2018-19, raising an additional demand of Rs. 48,22,435. The order was received on March 24, 2026 at 2.51 p.m. The company, however, believes that the demand is not maintainable and is planning to file an appeal. The company does not foresee any material impact on its financials, operations, or other activities due to this order.

Fortis Malar Hospitals Ltd, in compliance with SEBI circulars, disclosed the status of re-lodgement of transfer requests of physical shares for the months of January and February 2026. Notably, there were no rejected transfer requests during this period. The company's Registrar and Share Transfer Agent, M/s KFin Technologies Limited, reported this information.

Fortis Malar Hospitals Ltd. has sent a postal ballot notice to its members for approval on the following proposals: 1. Appointment of Mr. Bidesh Chandra Paul as a director and Whole-Time Director, 2. Re-appointment of Ms. Shailaja Chandra as an Independent Director for a second term of 5 consecutive years. The notice also includes the details of the resolutions, the scrutinizer's details, and the remote e-voting period.